| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_196837205377f53b549855622783a8e1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 |
| filingDate |
1982-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebf1aa0abe39db1425a417271c6a270e |
| publicationDate |
1987-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4713370-A |
| titleOfInvention |
Carnitine and its use in reducing cardiac toxicity and as a synergist with cytostats |
| abstract |
Carnitine may be administered for the purpose of reducing cardiac toxicity resulting from administration of a cytostat. Carnitine may also be administered in combination with cytostats to produce synergistic cytostatic activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9066974-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005232911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4827164-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9095606-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009143464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006258744-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008194683-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006183798-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003199535-A1 |
| priorityDate |
1972-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |